Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae

BMC Infectious Diseases

Volumn 4, Issue , 2004, Pages

  Lee, Haa Yung ^a   Andalibi, Ali ^a,b   Webster, Paul ^a,b   Moon, Sung Kyun ^a,e   Teufert, Karen ^a   Kang, Sung Ho ^a,f   Li, Jian Dong ^a,b   Nagura, Mitsuyoshi ^a,g   Ganz, Tomas ^d   Lim, David J ^a,c  

^a HOUSE EAR INSTITUTE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Ajou University School of Medicine   (South Korea)

^f Konkuk University Hospital   (South Korea)

^g HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA DEFENSIN 1; BETA DEFENSIN 2; LACTOFERRIN; LYSOZYME;

ANTIMICROBIAL ACTIVITY; ARTICLE; ARTIFACT; ASSAY; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG POTENTIATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GROWTH INHIBITION; HAEMOPHILUS INFLUENZAE; MIDDLE EAR; MORAXELLA CATARRHALIS; NONHUMAN; OTITIS MEDIA; RESPIRATORY TRACT MUCOSA; STREPTOCOCCUS PNEUMONIAE; STUDENT T TEST; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ANTI-INFECTIVE AGENTS; BETA-DEFENSINS; HAEMOPHILUS INFLUENZAE; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, TRANSMISSION; MORAXELLA (BRANHAMELLA) CATARRHALIS; MURAMIDASE; OTITIS MEDIA; STREPTOCOCCUS PNEUMONIAE;

EID: 10444227185     PISSN: 14712334     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2334-4-12     Document Type: Article

References (57)

1. Bluestone C, Klein J: Otits media in infants and children. 2nd edition. Philadelphia: W.B. Saunders Company; 1995.
2. Maxson S, Yamauchi T: Acute otitis media. Pediatr Rev 1996, 17(6):191-195. quiz 196
3. Shuto T, Imasato A, Jono H, Sakai A, Xu H, Watanabe T, Rixter DD, Kai H, Andalibi A, Linthicum F, et al.: Glucocorticoids synergistically enhance nontypeable Haemophilus influenzae-induced Toll-like receptor 2 expression via a negative cross-talk with p38 MAP kinase. J Biol Chem 2002, 277(19):17263-17270.
4. Dagan R: Treatment of acute otitis media - challenges in the era of antibiotic resistance. Vaccine 2000, 19 Suppl 1: 9-S16.
5. Rosenfeld R, Bluestone C: Evidence-Based Otitis Media. Saint Louis: BC Decker Inc 1999.
6. Bakaletz L: Otits Media. In: Polymicrobial Diseases Edited by: Brogden K, Guthmiller J. Washington, D.C.: ASM Press; 2002.
7. Ichimiya I, Kawauchi H, Mogi G: Analysis of immunocompetent cells in the middle ear mucosa. Arch Otolaryngol Head Neck Surg 1990, 116(3):324-330.
8. Prellner K, Kalm O, Pedersen FK: Pneumococcal antibodies and complement during and after periods of recurrent otitis. Int J Pediatr Otorhinolaryngol 1984, 7(1):39-49.
9. Ryan AF: Immune-mediated otitis media in an animal model. Ann Otol Rhinol Laryngol Suppl 1988, 132:24-27.
10. Teele DW, Klein JO, Rosner B: Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis 1989, 160(1): 3-94.
11. Boe R, Silvola J, Yang J, Moens U, McCray PB Jr, Stenfors LE, Seljfelid R: Human beta-defensin-1 mRNA is transcribed in tympanic membrane and adjacent auditory canal epithelium. Infect Immun 1999, 67(9):4843-4846.
12. Lim DJ: Functional morphology of the mucosa of the middle ear and Eustachian tube. Ann Otol Rhinol Laryngol 1976, 85(2 Suppl 25 Pt 2):36-43.
13. Lim DJ, Chun YM, Lee HY, Moon SK, Chang KH, Li JD, Andalibi A: Cell biology of tubotympanum in relation to pathogenesis of otitis media - a review. Vaccine 2000, 19 Suppl 1:S17-25.
14. Nonomura N, Giebink GS, Zelterman D, Harada T, Juhn SK: Middle ear fluid lysozyme source in experimental pneumococcal otitis media. Ann Otol Rhinol Laryngol 1991, 100(7):593-596.
15. Park K, Lim DJ: Development of secretory elements in murine tubotympanum: lysozyme and lactoferrin immunohistochemistry. Ann Otol Rhinol Laryngol 1993, 102(5):385-395.
16. Suzuki T, Somekawa Y, Yamanaka N, Niida Y, Kataura A: Lactoferrin in middle ear effusion. Auris Nasus Larynx 1985, 12 Suppl 1:S154-155.
17. Imasato A, Desbois-Mouthon C, Han J, Kai H, Cato AC, Akira S, Li JD: Inhibition of p38 MAPK by glucocorticoids via induction of MAPK phosphatase-1 enhances nontypeable Haemophilus influenzae-induced expression of toll-like receptor 2. J Biol Chem 2002, 277(49):47444-47450.
18. Hanamure Y, Lim DJ: Normal distribution of lysozyme- and lactoferrin-secreting cells in the chinchilla tubotympanum. Am J Otolaryngol 1986, 7(6):410-425.
19. Lim DJ, Liu YS, Birck H: Secretory lysozyme of the human middle ear mucosa: immunocytochemical localization. Ann Otol Rhinol Laryngol 1976, 85(1 Pt 1):50-60.
20. Liu YS, Lim DJ, Lang RW, Birck HG: Chronic middle ear effusions. Immunochemical and bacteriological investigations. Arch Otolaryngol 1975, 101(5):278-286.
21. Stenfors LE: Non-specific and specific immunity to bacterial invasion of the middle ear cavity. Int J Pediatr Otorhinolaryngol 1999, 49 Suppl 1:S223-226.
22. Chung MH, Choi JY, Lee WS, Kim HN, Yoon JH: Compositional difference in middle ear effusion: mucous versus serous. Laryngoscope 2002, 112(1):152-155.
23. Harada T, Juhn SK, Adams GL: Lysozyme levels in middle ear effusion and serum in otitis media. Arch Otolaryngol Head Neck Surg 1990, 116(1):54-56.
24. Moon SK, Lee HY, Li JD, Nagura M, Kang SH, Chun YM, Linthicum FH, Ganz T, Andalibi A, Lim DJ: Activation of a Src-dependent Raf-MEKl/2-ERK signaling pathway is required for IL-1 alphainduced upregulation of beta-defensin 2 in human middle ear epithelial cells. Biochim Biophys Acta 2002, 1590(1-3):41-51.
25. Watt SA, Kular G, Fleming IN, Downes CP, Lucocq JM: Subcellular localization of phosphatidylinositol 4,5-bisphosphate using the pleckstrin homology domain of phospholipase C deltal. Biochem J 2002, 363(Pt 3):657-666.
26. Lim DJ, DeMaria TF: Immunobarriers of the tubotympanum. Acta Otolaryngol 1987, 103(5-6):355-362.
27. Mogi G, Maeda S, Watanabe N: The development of mucosal immunity in guinea pig middle ears. Int J Pediatr Otorhinolaryngol 1980, 1(4):331-349.
28. Hu WG, Chen J, Battey JF, Gu XX: Enhancement of clearance of bacteria from murine lungs by immunization with detoxified lipooligosaccharide from Moraxella catarrhalis conjugated to proteins. Infect Immun 2000, 68(9):4980-4985.
29. Hausdorff WP, Yothers G, Dagan R, Kilpi T, Pelton SI, Cohen R, Jacobs MR, Kaplan SL, Levy C, Lopez EL, et al.: Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr Infect Dis J 2002, 21(11 ):1008-1016.
30. Harder J, Bartels J, Christophers E, Schroder JM: A peptide antibiotic from human skin. Nature 1997, 387(6636 : 61.
31. Hiratsuka T, Nakazato M, Date Y, Ashitani J, Minematsu T, Chino N, Matsukura S: Identification of human beta-defensin-2 in respiratory tract and plasma and its increase in bacterial pneumonia. Biochem Biophys Res Commun 1998, 249(3):943-947.
32. Liu AY, Destoumieux D, Wong AV, Park CH, Valore EV, Liu L, Ganz T: Human beta- defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. J Invest Dermatol 2002, 118(2):275-281.
33. Mathews M, Jia HP, Guthmiller JM, Losh G, Graham S, Johnson GK, Tack BF, McCray PB Jr: Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands. Infect Immun 1999, 67(6):2740-2745.
34. Lehrer RI, Ganz T: Antimicrobial peptides in mammalian and insect host defence. Curr Opin Immunol 1999, 11(1): 23-27.
35. McNamara N, Van R, Tuchin OS, Fleiszig SM: Ocular surface epithelia express mRNA for human beta defensin-2. Exp Eye Res 1999, 69(5):483-490.
36. Ganz T, Lehrer RI: Antimicrobial peptides of vertebrates. Curr Opin Immunol 1998, 10(1):41-44.
37. Schroder JM, Harder J: Human beta-defensin-2. Int J Biochem Cell Biol 1999, 31(6):645-651.
38. Starner TD, Swords WE, Apicella MA, McCray PB Jr: Susceptibility of nontypeable Haemophilus influenzae to human betadefensins is influenced by lipooligosaccharide acylation. Infect Immun 2002, 70(9):5287-5289.
39. Lehrer RI, Rosenman M, Harwig SS, Jackson R, Eisenhauer P: Ultrasensitive assays for endogenous antimicrobial polypeptides. J Immunol Methods 1991, 137(2):167-173.
40. O'Neil DA, Porter EM, Elewaut D, Anderson GM, Eckmann L, Ganz T, Kagnoff MF: Expression and regulation of the human betadefensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol 1999, 163(12):6718-6724.
41. Schnapp D, Reid CJ, Harris A: Localization of expression of human beta defensin-1 in the pancreas and kidney. J Pathol 1998, 186(1):99-103.
42. Bals R, Goldman MJ, Wilson JM: Mouse beta-defensin 1 is a saltsensitive antimicrobial peptide present in epithelia of the lung and urogenital tract. Infect Immun 1998, 66(3):1225-1232.
43. Singh PK, Jia HP, Wiles K, Hesselberth J, Liu L, Conway BA, Greenberg EP, Valore EV, Welsh MJ, Ganz T, et al.: Production of betadefensins by human airway epithelia. Proc Natl Acad Sci USA 1998, 95(25):14961-14966.
44. Dohrman A, Tsuda T, Escudier E, Cardone M, Jany B, Gum J, Kim Y, Basbaum C: Distribution of lysozyme and mucin (MUC2 and MUC3) mRNA in human bronchus. Exp Lung Res 1994, 20(4):367-380.
45. Klockars M, Osserman EF: Localization of lysozyme in normal rat tissues by an immunoperoxidase method. J Histochem Cytochem 1974, 22(3):139-146.
46. Klockars M, Reitamo S: Tissue distribution of lysozyme in man. J Histochem Cytochem 1975, 23(12):932-940.
47. Montagne P, Cuilliere ML, Mole C, Bene MC, Faure G: Changes in lactoferrin and lysozyme levels in human milk during the first twelve weeks of lactation. Adv Exp Med Biol 2 001, 501: 41-247.
48. Chun W, Hancock RE: Action of lysozyme and nisin mixtures against lactic acid bacteria. Int J Food Microbiol 2000, 60(1):25-32.
49. Aebi C, Stone B, Beucher M, Cope LD, Maciver I, Thomas SE, McCracken GH Jr, Sparling PF, Hansen EJ: Expression of the CopB outer membrane protein by Moraxella catarrhalis is regulated by iron and affects iron acquisition from transferrin and lactoferrin. Infect Immun 1996, 64(6):2024-2030.
50. Bonnah RA, Yu RH, Wong H, Schryvers AB: Biochemical and immunological properties of lactoferrin binding proteins from Moraxella (Branhamella) catarrhalis. Microb Pathog 1998, 24(2): 9-100.
51. Ellison RT 3rd: The effects of lactoferrin on gram-negative bacteria. Adv Exp Med Biol 1994, 357:71-90.
52. Qiu J, Hendrixson DR, Baker EN, Murphy TF, St Geme JW 3rd, Plaut AG: Human milk lactoferrin inactivates two putative colonization factors expressed by Haemophilus influenzae. Proc Natl Acad Sci USA 1998, 95(21):12641-12646.
53. Hanson LA, Korotkova M, Haversen L, Mattsby-Baltzer I, Hahn-Zoric M, Silfverdal SA, Strandvik B, Telemo E: Breast-feeding, a complex support system for the offspring. Pediatr Int 2002, 44(4):347-352.
54. Plaut AG, Qiu J, St Geme JW 3rd: Human lactoferrin proteolytic activity: analysis of the cleaved region in the IgA protease of Haemophilus influenzae. Vaccine 2000, 19 Suppl 1: 148-152.
55. Wu H, Kuzmenko A, Wan S, Schaffer L, Weiss A, Fisher JH, Kim KS, McCormack FX: Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J Clin Invest 2003, 111(10):1589-1602.
56. Shimoda M, Ohki K, Shimamoto Y, Kohashi O: Morphology of defensin-treated Staphylococcus aureus. Infect Immun 1995, 63(8):2886-2891.
57. Singh PK, Tack BF, McCray PB Jr, Welsh MJ: Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am J Physiol Lung Cell Mol Physiol 2000, 279(5 : 799-805.